Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Brontictuzumab |
| Trade Name | |
| Synonyms | OMP-52M51 |
| Drug Descriptions |
Brontictuzumab (OMP-52M51) is a monoclonal antibody that binds Notch1 and prevents ligand interaction and pathway activation, which may inhibit angiogenesis and tumor growth (PMID: 23774673, PMID: 31616059, PMID: 29726923). |
| DrugClasses | NOTCH1 Antibody 2 |
| CAS Registry Number | 1447814-75-6 |
| NCIT ID | C103274 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Brontictuzumab | Brontictuzumab | 0 | 2 |
| Brontictuzumab + Trifluridine | Brontictuzumab Trifluridine | 0 | 1 |